LGALS3 and diabetic neuropathy: The observed reduction in perineural thickness, elevation of plasma FGF21 levels, and reduction in gal3 and MDA levels collectively suggest that diosmin and hesperidin could be valuable agents in mitigating the underlying pathophysiology of diabetic neuropathy.